arnuity-containers.png

The US Food and Drug Administration (FDA) has expanded the use of the inhaled corticosteroid fluticasone furoate (Arnuity Ellipta, GlaxoSmithKline) as a once-daily asthma maintenance treatment for children as young as age 5 years.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()